Company intelligence / Profile preview

Ipsogen

Marseille, France

Ownership: Private
Development stage: Other

Overview

Ipsogen developed a comprehensive portfolio of blood cancer and breast cancer diagnostic products available in more than 50 countries. The company specialized in translating molecular discoveries into industry-standard diagnostic tools for personalized cancer treatment.

Therapeutic areas: HematologyOncology
Modalities: Molecular diagnostic assaysGene expression profilingDNA/RNA testing
Industry: Molecular Diagnostics

Partnerships

LabCorp (non-exclusive license agreement for blood-based cancer assays in the United States)Warnex (JAK2 assay distribution in Canada)

Beyond the preview

Go deeper on Ipsogen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ipsogen.

Explore the full profile